[Hormone therapy and the risk of cancer in the climacteric].
D001943:Breast Neoplasms / Q000139:chemically induced*; D002455:Cell Division / Q000187:drug effects; D002979:Climacteric / Q000187:drug effects*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D045166:Estradiol Congeners / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D045167:Progesterone Congeners / Q000009:adverse effects* / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood; D012306:Risk; D014594:Uterine Neoplasms / Q000139:chemically induced*
D045166:Estradiol Congeners; D045167:Progesterone Congeners; D011388:Prolactin
Hormontherapie und Karzinomrisiko im Klimakterium.